Stock and Warrant Subscription Agreement Sample Contracts

Neurologix Letterhead]
Stock and Warrant Subscription Agreement • November 21st, 2007 • Neurologix Inc/De • Pharmaceutical preparations
STOCK AND WARRANT SUBSCRIPTION AGREEMENT
Stock and Warrant Subscription Agreement • May 13th, 2020 • Cardiff Oncology, Inc. • Biological products, (no disgnostic substances) • California

This Stock and Warrant Subscription Agreement (the “Agreement”) is entered into as of May 8, 2020 (the “Effective Date”), by and between Cardiff Oncology, Inc., a Delaware corporation (hereinafter the “Company”) and POC Capital, LLC, a California limited liability company (the “Subscriber”).

Neurologix, Inc. One Bridge Plaza Fort Lee, NJ 07024
Stock and Warrant Subscription Agreement • December 6th, 2010 • Neurologix Inc/De • Pharmaceutical preparations

Reference is made to (i) the Stock and Warrant Subscription Agreement, dated as of May 10, 2006, by and among Neurologix, Inc. (the “Company”), General Electric Pension Trust (“GE”), DaimlerChrysler Corporation Master Retirement Trust, n/k/a Chrysler Group LLC Master Retirement Trust (“Chrysler”), certain funds managed by ProMed Asset Management LLC, Paul Scharfer, and David Musket (“Musket”), as amended by letter agreement dated November 8, 2007 (such Stock and Warrant Subscription Agreement, as amended, is hereafter referred to as the “Series C Subscription Agreement”), (ii) the Stock and Warrant Subscription Agreement, dated as of November 19, 2007, by and among the Company, GE and Corriente Master Fund, L.P. (the “Series D Subscription Agreement”), and (iii) the Stock and Warrant Subscription Agreement, dated as of April 28, 2008, by and among the Company, GE and Corriente Master Fund, L.P. (the “Corriente Subscription Agreement”). Capitalized terms used but not defined herein shal

WITNESSETH:
Stock and Warrant Subscription Agreement • May 11th, 2006 • Neurologix Inc/De • Pharmaceutical preparations • New York
STOCK AND WARRANT SUBSCRIPTION AGREEMENT
Stock and Warrant Subscription Agreement • November 21st, 2007 • Neurologix Inc/De • Pharmaceutical preparations • New York

THIS STOCK AND WARRANT SUBSCRIPTION AGREEMENT (the “Agreement”) is made as of November 19, 2007 by and between Neurologix, Inc., a Delaware corporation (the “Company”), and the investors set forth on Exhibit A hereto (individually, an “Investor” and collectively, the “Investors”) and, solely with respect to Sections 3.2 and 3.3, (i) Martin J. Kaplitt, M. D. and (ii) Palisade Private Holdings LLC (“Palisade”) ((i) – (ii) together, the “Holders”).

STOCK AND WARRANT SUBSCRIPTION AGREEMENT
Stock and Warrant Subscription Agreement • April 30th, 2008 • Neurologix Inc/De • Pharmaceutical preparations • New York

THIS STOCK AND WARRANT SUBSCRIPTION AGREEMENT (the “Agreement”) is made as of April 28, 2008 by and between Neurologix, Inc., a Delaware corporation (the “Company”), Corriente Master Fund, L.P. (“Corriente”) and, solely with respect to Article V of the Agreement, General Electric Pension Trust (“GE”). Capitalized terms used herein, but not otherwise defined, shall have the meanings set forth in that certain Stock and Warrant Subscription Agreement, dated November 19, 2007, by and among the Company and the signatories thereto (the “Original Series D Agreement”).